Results 191 to 200 of about 4,984,276 (289)

Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis [PDF]

, 2016
Jinming Song, Mohammad Hussaini, Hailing Zhang, Haipeng Shao, Dahui Qin, Xiaohui Zhang, Zhenjun Ma, Syeda Mahrukh Hussnain Naqvi, Ling Zhang, Lynn C. Moscinski   +9 more
openalex   +1 more source

Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: results from a multicenter cooperative study. [PDF]

Ann Hematol
Cavalca F, Latagliata R, Pugliese N, Palumbo GA, Polverelli N, Musto P, Benevolo G, Branzanti F, Di Veroli A, Buttini EA, Ripamonti A, Civettini I, Montelisciani L, Antolini L, Gambacorti-Passerini C, Palandri F, Elli EM.   +16 more
europepmc   +1 more source

Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.

Blood, 2017
P. Guglielmelli, Annalisa Pacilli, G. Rotunno, E. Rumi, V. Rosti, F. Delaini, M. Maffioli, Tiziana Fanelli, A. Pancrazzi, D. Pietra, S. Salmoiraghi, C. Mannarelli, A. Franci, C. Paoli, A. Rambaldi, F. Passamonti, G. Barosi, T. Barbui, Mario Cazzola, A. Vannucchi   +19 more
semanticscholar   +1 more source

Metformin Downregulates the STAT Pathway and Reduces Bone Marrow Fibrosis in Primary Myelofibrosis Patients: Final Results of the Phase II FIBROMET Trial. [PDF]

Hematol Oncol
Melo Campos P, Pagnano KBB, Niemann FS, Mancuso RI, Della Via FI, Congrains A, Coelho-Silva JL, Tinoco ÂC, Assis-Mendonça GR, Freitas LLL, Traina F, Saad STO.   +11 more
europepmc   +1 more source

Somatically acquired mutations in primary myelofibrosis: A case report and meta‑analysis

, 2021
Yongming Xia, Qingxiao Hong, Zhibin Gao, Shijun Wang, Shiwei Duan   +4 more
openalex   +2 more sources

Chronic Inflammation in Primary Myelofibrosis: In-Depth Insights Into Pathogenesis and Promising Anti-Inflammatory Therapeutic Strategies. [PDF]

Mediators Inflamm
Chen M, Zheng C, Zhang Y, He J, Shi Z.
europepmc   +1 more source

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies [PDF]

, 2014
DiPersio, John F, et al,
core   +1 more source

JAK2 exon 12 mutations in cases with JAK2V617F-negative polycythemia vera and primary myelofibrosis

Annals of Hematology, 2020
Madhavi Maddali, U. Kulkarni, N. Ravindra, Ekta Jajodia, A. Arunachalam, Hemamalini Suresh, Arvind Venkatraman, B. George, V. Mathews, P. Balasubramanian   +9 more
semanticscholar   +1 more source

Inhibiting the alarmin-driven hematopoiesis-stromal cell crosstalk in primary myelofibrosis ameliorates bone marrow fibrosis. [PDF]

Hemasphere
Gleitz HFE, Fuchs SNR, Snoeren IAM, Boys C, Nagai J, Tejeda-Mora H, Klöker V, Pritchard JE, Bakker IJ, Gargallo Garasa M, Bindels E, Saez-Rodriguez J, Vogl T, Kramann R, Dugourd A, Costa IG, Schneider RK.   +16 more
europepmc   +1 more source

Basophilia and eosinophilia in primary myelofibrosis: phenotype, genotype, and prognostic correlates. [PDF]

Blood Cancer J
Dingli S, Fathima S, Faldu P, Gangat N, Dingli D, Tefferi A.   +5 more
europepmc   +1 more source